Gilbert Omenn

Gil Omenn is a Professor of Computational Medicine & Bioinformatics at the University of Michigan, with additional appointments in Internal Medicine, Human Genetics, and Public Health. He previously served as Executive Vice President for Medical Affairs at UM (1997-2002) and Dean of the University of Washington School of Public Health (1982-1997). A White House Fellow and National Academy of Medicine member, he leads the global Human Proteome Project (HPP) under HUPO.

• Education:
  • B.A., Princeton University
  • M.D., Harvard Medical School
  • Ph.D., University of Washington (Genetics)
• Affiliations:
  • University of Michigan (current)
  • Peking Union Medical College (Honorary Faculty)
  • Institute for Systems Biology (Affiliate Faculty)
  • Weizmann Institute (Board Member)
  • Biotech companies (Director)

Research focuses on proteogenomics of alternative splicing in cancers, exploring splice variants as biomarkers and therapeutic targets. His work bridges computational medicine, AI in drug discovery, and global health initiatives like π-HuB for mapping human proteomics.

Recent publications highlight AI applications in medicine, pan-cancer proteogenomics, and circulating proteome analysis. His scientific leadership includes:

• Member, U.S. National Academy of Medicine
• White House Fellow (Atomic Energy Commission)

He has contributed to multinational studies on:

• Neurological outcomes in hospitalized COVID-19 patients
• AML proteogenomics
• Pancreatic adenocarcinoma characterization